
ArthroCare Corp. (Nasdaq: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced results from its five-year study evaluating the effectiveness of the TOPAZ MicroDebrider to treat common tendon disorders, and concluded patients who had the minimally invasive procedure were highly satisfied with the procedure and continue to experience pain relief.
Click here for full Story http://www.medicalnewstoday.com/articles/106837.php |